An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy.
Rosse
R B
RB
Psychiatry Service, Department of Veterans Affairs Medical Center, Washington, D.C. 20422.
Schwartz
B L
BL
Leighton
M P
MP
Davis
R E
RE
Deutsch
S I
SI
D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology*; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
D000081:Acetamides; D016194:Receptors, N-Methyl-D-Aspartate; C039332:milacemide